Search Tag: PET imaging
2025 13 Aug
Radiomics enables the extraction of quantitative features from medical images, offering detailed descriptors of tumour physiology that surpass visual interpretation. These radiomic features can be used to predict tumour heterogeneity, aggressiveness, treatment response and survival outcomes, thereby advancing precision medicine. For these predictions...Read more
2025 31 Jul
Lymphovascular invasion (LVI) is a critical determinant of prognosis in colorectal cancer (CRC), reflecting a tumour’s capacity for dissemination through blood and lymphatic vessels. Accurate preoperative assessment of LVI could inform treatment decisions and improve outcomes, yet remains limited by the need for postoperative histological confirmation....Read more
2025 31 Jul
Lymphovascular invasion (LVI) is a critical determinant of prognosis in colorectal cancer (CRC), reflecting a tumour’s capacity for dissemination through blood and lymphatic vessels. Accurate preoperative assessment of LVI could inform treatment decisions and improve outcomes, yet remains limited by the need for postoperative histological confirmation....Read more
2025 15 Jun
Prostate-specific membrane antigen (PSMA) PET imaging has become a key tool in the detection and staging of prostate cancer, offering improved diagnostic capabilities over traditional imaging methods. However, variability in how these scans are interpreted has posed challenges for consistent clinical decision-making. The introduction of the PSMA...Read more
2025 17 Feb
Prostate cancer remains one of the most prevalent malignancies in men, with early and accurate detection playing a crucial role in determining patient outcomes. Conventional imaging techniques such as MRI, CT and bone scans often struggle to identify small or early-stage metastatic lesions, particularly in cases of biochemical recurrence (BCR)....Read more
2024 16 Nov
Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive non-Hodgkin lymphoma, accounting for approximately 30% of cases in Western countries. DLBCL patients experience varied outcomes depending on disease stage, tumour burden and individual health profiles. For years, the International Prognostic Index (IPI) has served as a critical tool...Read more